S Squared Technology LLC Makes New $1.06 Billion Investment in DocGo Inc. $DCGO

S Squared Technology LLC purchased a new stake in shares of DocGo Inc. (NASDAQ:DCGO) in the second quarter, according to its most recent filing with the Securities & Exchange Commission. The firm purchased 2,055,271 shares of the company’s stock, valued at approximately $1,060,725,000.

Several other large investors have also recently made changes to their positions in the stock. Neuberger Berman Group LLC purchased a new position in shares of DocGo during the 4th quarter worth approximately $29,000. Cerity Partners LLC acquired a new stake in DocGo in the 2nd quarter valued at approximately $37,000. Public Employees Retirement System of Ohio purchased a new stake in DocGo in the fourth quarter valued at approximately $40,000. Engineers Gate Manager LP purchased a new stake in DocGo in the second quarter valued at approximately $52,000. Finally, Diversify Advisory Services LLC acquired a new position in DocGo during the second quarter worth $53,000. 56.44% of the stock is currently owned by institutional investors and hedge funds.

DocGo Stock Down 12.2%

Shares of DCGO stock opened at $0.38 on Tuesday. The firm has a 50 day moving average of $0.58 and a two-hundred day moving average of $0.63. The stock has a market capitalization of $37.68 million, a PE ratio of -0.19 and a beta of 0.99. DocGo Inc. has a 52 week low of $0.38 and a 52 week high of $1.73.

DocGo (NASDAQ:DCGO) last announced its quarterly earnings data on Monday, August 17th. The company reported ($0.16) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.10) by ($0.06). DocGo had a negative net margin of 65.29% and a negative return on equity of 40.42%. The company had revenue of $73.42 million during the quarter, compared to analyst estimates of $75.35 million. Analysts expect that DocGo Inc. will post -0.17 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

Several research analysts have recently commented on the company. Cantor Fitzgerald restated an “overweight” rating on shares of DocGo in a research report on Monday, May 11th. Needham & Company LLC reissued a “buy” rating and set a $3.00 target price on shares of DocGo in a research note on Tuesday, August 18th. Weiss Ratings restated a “sell (e+)” rating on shares of DocGo in a report on Thursday, June 18th. Wall Street Zen raised DocGo from a “sell” rating to a “hold” rating in a research report on Saturday, May 16th. Finally, Canaccord Genuity Group reiterated a “hold” rating and set a $1.00 price target on shares of DocGo in a research note on Tuesday, August 18th. Three equities research analysts have rated the stock with a Buy rating, two have given a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat, the company currently has an average rating of “Hold” and a consensus target price of $2.38.

DocGo Company Profile

DocGo, Inc is a U.S.-based integrated healthcare company that delivers on-demand and mobile healthcare services. The company’s business model centers on deploying customized medical clinics paired with a digital care platform to bring primary and acute care directly to patients. Through a combination of telemedicine and over-the-road medical units, DocGo addresses routine medical exams, chronic disease management, occupational health screenings, specialist consultations and urgent care interventions.

In addition to its mobile clinic fleet, DocGo’s digital platform offers 24/7 virtual care, facilitating remote consultations via video, phone or secure messaging.